Teng, C., Reveles, K. R., Obodozie-Ofoegbu, O. O., & Frei, C. R. (2019). Clostridium difficile Infection Risk with Important Antibiotic Classes: An Analysis of the FDA Adverse Event Reporting System. Int J Med Sci.
シカゴスタイル引用形Teng, Chengwen, Kelly R. Reveles, Obiageri O. Obodozie-Ofoegbu, , Christopher R. Frei. "Clostridium Difficile Infection Risk With Important Antibiotic Classes: An Analysis of the FDA Adverse Event Reporting System." Int J Med Sci 2019.
MLA引用形式Teng, Chengwen, Kelly R. Reveles, Obiageri O. Obodozie-Ofoegbu, , Christopher R. Frei. "Clostridium Difficile Infection Risk With Important Antibiotic Classes: An Analysis of the FDA Adverse Event Reporting System." Int J Med Sci 2019.
警告: この引用は必ずしも正確ではありません.